Chief Executive OfficerTerry Pizzie

Terry has been working in the biotech tools sector for more than 30 years. Prior to joining Astrea Bioseparations, Terry was most recently CEO of Cambridge based Horizon Discovery PLC, a public company listed on the UK AIM market. He was at Horizon for 4 years prior to it being acquired by Perkin Elmer Corp and has spent the last 6 months ensuring a smooth integration of the business into its new home. Previous roles were VP Global Sales for Pacific Biosciences and lead commercial positions at Genetix PLC, aquired by Danaher Corp., and at the Swedish Biotech company Biacore, acquired by GE. Terry started his career in this sector at Applied Biosystems in 1988 in a regional sales role and rose to VP Europe by 2003. Terry graduated with a degree in Physiology and Biochemistry from Reading University.

Connect on